News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series
High insulin prices spur a federal lawsuit against three pharmacy benefit managers
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients.
FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices
Caremark, Express Scripts, Optum, and their affiliates created a broken rebate system that inflated insulin drug prices, boosting PBM profits at the expense of vulnerable patients, the FTC alleges.
The Opaque Industry Secretly Inflating Prices for Prescription Drugs
Pharmacy Benefit Managers (PBMs) are driving up drug costs for millions of people, employers and the government.
The second in “THE MIDDLEMEN” series of articles by reporters Rebecca Robins and Reed Abelson investigating PBMs.